Gregory RI, Chendrimada TP, Shiekhattar R (2006). "MicroRNA biogenesis: isolation and characterization of the microprocessor complex". MicroRNA Protocols. Methods in Molecular Biology. Vol. 342. pp. 33–47. doi:10.1385/1-59745-123-1:33. ISBN978-1-59745-123-9. PMID16957365.
Pillai RS, Bhattacharyya SN, Filipowicz W (2007). "Repression of protein synthesis by miRNAs: how many mechanisms?". Trends Cell Biol. 17 (3): 118–26. doi:10.1016/j.tcb.2006.12.007. PMID17197185.
Sen G, Blau H (2005). "Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies". Nat Cell Biol. 7 (6): 633–6. doi:10.1038/ncb1265. PMID15908945. S2CID6085169.
Jakymiw A, Lian S, Eystathioy T, Li S, Satoh M, Hamel J, et al. (2005). "Disruption of P bodies impairs mammalian RNA interference". Nat Cell Biol. 7 (12): 1267–74. doi:10.1038/ncb1334. PMID16284622. S2CID36630239.
Holmquist GP, Ashley T (2006). "Chromosome organization and chromatin modification: influence on genome function and evolution". Cytogenetic and Genome Research. 114 (2): 96–125. doi:10.1159/000093326. PMID16825762. S2CID29910065.
Volpe T, Schramke V, Hamilton GL, White SA, Teng G, Martienssen RA, et al. (2003). "RNA interference is required for normal centromere function in fission yeast". Chromosome Research. 11 (2): 137–46. doi:10.1023/A:1022815931524. PMID12733640. S2CID23813417.
DaRocha WD, Otsu K, Teixeira SM, Donelson JE (February 2004). "Tests of cytoplasmic RNA interference (RNAi) and construction of a tetracycline-inducible T7 promoter system in Trypanosoma cruzi". Molecular and Biochemical Parasitology. 133 (2): 175–86. doi:10.1016/j.molbiopara.2003.10.005. PMID14698430.
Robinson KA, Beverley SM (May 2003). "Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania". Molecular and Biochemical Parasitology. 128 (2): 217–28. doi:10.1016/S0166-6851(03)00079-3. PMID12742588.
Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O'Riordan WD, Cochat P, et al. (1 April 2021). "Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1". The New England Journal of Medicine. 384 (13): 1216–1226. doi:10.1056/NEJMoa2021712. ISSN1533-4406. PMID33789010.
Adams D, Tournev IL, Taylor MS, Coelho T, Planté-Bordeneuve V, Berk JL, et al. (March 2023). "Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial". Amyloid. 30 (1): 18–26. doi:10.1080/13506129.2022.2091985. hdl:1959.4/unsworks_80922. ISSN1744-2818. PMID35875890.
Gonzalez-Aseguinolaza G (11 June 2020). "Givosiran — Running RNA Interference to Fight Porphyria Attacks". New England Journal of Medicine. 382 (28–4793): 2366–2367. doi:10.1056/NEJMe2010986. PMID32521139. S2CID219592948.
Li YC, Kong LH, Cheng BZ, Li KS (December 2005). "Construction of influenza virus siRNA expression vectors and their inhibitory effects on multiplication of influenza virus". Avian Diseases. 49 (4): 562–73. doi:10.1637/7365-041205R2.1. PMID16405000. S2CID86214047.
Khanna M, Saxena L, Rajput R, Kumar B, Prasad R (2015). "Gene silencing: a therapeutic approach to combat influenza virus infections". Future Microbiology. 10 (1): 131–40. doi:10.2217/fmb.14.94. PMID25598342.
Rajput R, Khanna M, Kumar P, Kumar B, Sharma S, Gupta N, et al. (December 2012). "Small interfering RNA targeting the nonstructural gene 1 transcript inhibits influenza A virus replication in experimental mice". Nucleic Acid Therapeutics. 22 (6): 414–22. doi:10.1089/nat.2012.0359. PMID23062009.
Fuchs U, Damm-Welk C, Borkhardt A (August 2004). "Silencing of disease-related genes by small interfering RNAs". Current Molecular Medicine. 4 (5): 507–17. doi:10.2174/1566524043360492. PMID15267222.
Niggeweg R, Michael AJ, Martin C (June 2004). "Engineering plants with increased levels of the antioxidant chlorogenic acid". Nature Biotechnology. 22 (6): 746–54. doi:10.1038/nbt966. PMID15107863. S2CID21588259.
Gilbert MK, Majumdar R, Rajasekaran K, Chen ZY, Wei Q, Sickler CM, et al. (June 2018). "RNA interference-based silencing of the alpha-amylase (amy1) gene in Aspergillus flavus decreases fungal growth and aflatoxin production in maize kernels". Planta. 247 (6): 1465–1473. Bibcode:2018Plant.247.1465G. doi:10.1007/s00425-018-2875-0. PMID29541880. S2CID3918937.
Katoch R, Thakur N (March 2013). "RNA interference: a promising technique for the improvement of traditional crops". International Journal of Food Sciences and Nutrition. 64 (2): 248–59. doi:10.3109/09637486.2012.713918. PMID22861122. S2CID45212581.
Katoch R, Thakur N (March 2013). "Advances in RNA interference technology and its impact on nutritional improvement, disease and insect control in plants". Applied Biochemistry and Biotechnology. 169 (5): 1579–605. doi:10.1007/s12010-012-0046-5. PMID23322250. S2CID23733295.
Huesken D, Lange J, Mickanin C, Weiler J, Asselbergs F, Warner J, et al. (August 2005). "Design of a genome-wide siRNA library using an artificial neural network". Nature Biotechnology. 23 (8): 995–1001. doi:10.1038/nbt1118. PMID16025102. S2CID11030533.
Janitz M, Vanhecke D, Lehrach H (2006). "High-Throughput RNA Interference in Functional Genomics". RNA Towards Medicine. Handbook of Experimental Pharmacology. Vol. 173. pp. 97–104. doi:10.1007/3-540-27262-3_5. ISBN978-3-540-27261-8. PMID16594612.
Romano N, Macino G (November 1992). "Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences". Molecular Microbiology. 6 (22): 3343–53. doi:10.1111/j.1365-2958.1992.tb02202.x. PMID1484489. S2CID31234985.
Ratcliff F, Harrison BD, Baulcombe DC (June 1997). "A similarity between viral defense and gene silencing in plants". Science. 276 (5318): 1558–60. doi:10.1126/science.276.5318.1558. PMID18610513.
Adams D, Tournev IL, Taylor MS, Coelho T, Planté-Bordeneuve V, Berk JL, et al. (March 2023). "Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial". Amyloid. 30 (1): 18–26. doi:10.1080/13506129.2022.2091985. hdl:1959.4/unsworks_80922. ISSN1744-2818. PMID35875890.
Gilbert MK, Majumdar R, Rajasekaran K, Chen ZY, Wei Q, Sickler CM, et al. (June 2018). "RNA interference-based silencing of the alpha-amylase (amy1) gene in Aspergillus flavus decreases fungal growth and aflatoxin production in maize kernels". Planta. 247 (6): 1465–1473. Bibcode:2018Plant.247.1465G. doi:10.1007/s00425-018-2875-0. PMID29541880. S2CID3918937.
Gregory RI, Chendrimada TP, Shiekhattar R (2006). "MicroRNA biogenesis: isolation and characterization of the microprocessor complex". MicroRNA Protocols. Methods in Molecular Biology. Vol. 342. pp. 33–47. doi:10.1385/1-59745-123-1:33. ISBN978-1-59745-123-9. PMID16957365.
Pillai RS, Bhattacharyya SN, Filipowicz W (2007). "Repression of protein synthesis by miRNAs: how many mechanisms?". Trends Cell Biol. 17 (3): 118–26. doi:10.1016/j.tcb.2006.12.007. PMID17197185.
Sen G, Blau H (2005). "Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies". Nat Cell Biol. 7 (6): 633–6. doi:10.1038/ncb1265. PMID15908945. S2CID6085169.
Jakymiw A, Lian S, Eystathioy T, Li S, Satoh M, Hamel J, et al. (2005). "Disruption of P bodies impairs mammalian RNA interference". Nat Cell Biol. 7 (12): 1267–74. doi:10.1038/ncb1334. PMID16284622. S2CID36630239.
Holmquist GP, Ashley T (2006). "Chromosome organization and chromatin modification: influence on genome function and evolution". Cytogenetic and Genome Research. 114 (2): 96–125. doi:10.1159/000093326. PMID16825762. S2CID29910065.
Volpe T, Schramke V, Hamilton GL, White SA, Teng G, Martienssen RA, et al. (2003). "RNA interference is required for normal centromere function in fission yeast". Chromosome Research. 11 (2): 137–46. doi:10.1023/A:1022815931524. PMID12733640. S2CID23813417.
DaRocha WD, Otsu K, Teixeira SM, Donelson JE (February 2004). "Tests of cytoplasmic RNA interference (RNAi) and construction of a tetracycline-inducible T7 promoter system in Trypanosoma cruzi". Molecular and Biochemical Parasitology. 133 (2): 175–86. doi:10.1016/j.molbiopara.2003.10.005. PMID14698430.
Robinson KA, Beverley SM (May 2003). "Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania". Molecular and Biochemical Parasitology. 128 (2): 217–28. doi:10.1016/S0166-6851(03)00079-3. PMID12742588.
Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O'Riordan WD, Cochat P, et al. (1 April 2021). "Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1". The New England Journal of Medicine. 384 (13): 1216–1226. doi:10.1056/NEJMoa2021712. ISSN1533-4406. PMID33789010.
Adams D, Tournev IL, Taylor MS, Coelho T, Planté-Bordeneuve V, Berk JL, et al. (March 2023). "Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial". Amyloid. 30 (1): 18–26. doi:10.1080/13506129.2022.2091985. hdl:1959.4/unsworks_80922. ISSN1744-2818. PMID35875890.
Gonzalez-Aseguinolaza G (11 June 2020). "Givosiran — Running RNA Interference to Fight Porphyria Attacks". New England Journal of Medicine. 382 (28–4793): 2366–2367. doi:10.1056/NEJMe2010986. PMID32521139. S2CID219592948.
Berkhout B (April 2004). "RNA interference as an antiviral approach: targeting HIV-1". Current Opinion in Molecular Therapeutics. 6 (2): 141–5. PMID15195925.
Li YC, Kong LH, Cheng BZ, Li KS (December 2005). "Construction of influenza virus siRNA expression vectors and their inhibitory effects on multiplication of influenza virus". Avian Diseases. 49 (4): 562–73. doi:10.1637/7365-041205R2.1. PMID16405000. S2CID86214047.
Khanna M, Saxena L, Rajput R, Kumar B, Prasad R (2015). "Gene silencing: a therapeutic approach to combat influenza virus infections". Future Microbiology. 10 (1): 131–40. doi:10.2217/fmb.14.94. PMID25598342.
Rajput R, Khanna M, Kumar P, Kumar B, Sharma S, Gupta N, et al. (December 2012). "Small interfering RNA targeting the nonstructural gene 1 transcript inhibits influenza A virus replication in experimental mice". Nucleic Acid Therapeutics. 22 (6): 414–22. doi:10.1089/nat.2012.0359. PMID23062009.
Hu L, Wang Z, Hu C, Liu X, Yao L, Li W, et al. (2005). "Inhibition of Measles virus multiplication in cell culture by RNA interference". Acta Virologica. 49 (4): 227–34. PMID16402679.
Fuchs U, Damm-Welk C, Borkhardt A (August 2004). "Silencing of disease-related genes by small interfering RNAs". Current Molecular Medicine. 4 (5): 507–17. doi:10.2174/1566524043360492. PMID15267222.
Niggeweg R, Michael AJ, Martin C (June 2004). "Engineering plants with increased levels of the antioxidant chlorogenic acid". Nature Biotechnology. 22 (6): 746–54. doi:10.1038/nbt966. PMID15107863. S2CID21588259.
Gilbert MK, Majumdar R, Rajasekaran K, Chen ZY, Wei Q, Sickler CM, et al. (June 2018). "RNA interference-based silencing of the alpha-amylase (amy1) gene in Aspergillus flavus decreases fungal growth and aflatoxin production in maize kernels". Planta. 247 (6): 1465–1473. Bibcode:2018Plant.247.1465G. doi:10.1007/s00425-018-2875-0. PMID29541880. S2CID3918937.
Katoch R, Thakur N (March 2013). "RNA interference: a promising technique for the improvement of traditional crops". International Journal of Food Sciences and Nutrition. 64 (2): 248–59. doi:10.3109/09637486.2012.713918. PMID22861122. S2CID45212581.
Katoch R, Thakur N (March 2013). "Advances in RNA interference technology and its impact on nutritional improvement, disease and insect control in plants". Applied Biochemistry and Biotechnology. 169 (5): 1579–605. doi:10.1007/s12010-012-0046-5. PMID23322250. S2CID23733295.
Huesken D, Lange J, Mickanin C, Weiler J, Asselbergs F, Warner J, et al. (August 2005). "Design of a genome-wide siRNA library using an artificial neural network". Nature Biotechnology. 23 (8): 995–1001. doi:10.1038/nbt1118. PMID16025102. S2CID11030533.
Janitz M, Vanhecke D, Lehrach H (2006). "High-Throughput RNA Interference in Functional Genomics". RNA Towards Medicine. Handbook of Experimental Pharmacology. Vol. 173. pp. 97–104. doi:10.1007/3-540-27262-3_5. ISBN978-3-540-27261-8. PMID16594612.
Romano N, Macino G (November 1992). "Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences". Molecular Microbiology. 6 (22): 3343–53. doi:10.1111/j.1365-2958.1992.tb02202.x. PMID1484489. S2CID31234985.
Ratcliff F, Harrison BD, Baulcombe DC (June 1997). "A similarity between viral defense and gene silencing in plants". Science. 276 (5318): 1558–60. doi:10.1126/science.276.5318.1558. PMID18610513.
Sen G, Blau H (2005). "Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies". Nat Cell Biol. 7 (6): 633–6. doi:10.1038/ncb1265. PMID15908945. S2CID6085169.
Jakymiw A, Lian S, Eystathioy T, Li S, Satoh M, Hamel J, et al. (2005). "Disruption of P bodies impairs mammalian RNA interference". Nat Cell Biol. 7 (12): 1267–74. doi:10.1038/ncb1334. PMID16284622. S2CID36630239.
Holmquist GP, Ashley T (2006). "Chromosome organization and chromatin modification: influence on genome function and evolution". Cytogenetic and Genome Research. 114 (2): 96–125. doi:10.1159/000093326. PMID16825762. S2CID29910065.
Volpe T, Schramke V, Hamilton GL, White SA, Teng G, Martienssen RA, et al. (2003). "RNA interference is required for normal centromere function in fission yeast". Chromosome Research. 11 (2): 137–46. doi:10.1023/A:1022815931524. PMID12733640. S2CID23813417.
Gonzalez-Aseguinolaza G (11 June 2020). "Givosiran — Running RNA Interference to Fight Porphyria Attacks". New England Journal of Medicine. 382 (28–4793): 2366–2367. doi:10.1056/NEJMe2010986. PMID32521139. S2CID219592948.
Li YC, Kong LH, Cheng BZ, Li KS (December 2005). "Construction of influenza virus siRNA expression vectors and their inhibitory effects on multiplication of influenza virus". Avian Diseases. 49 (4): 562–73. doi:10.1637/7365-041205R2.1. PMID16405000. S2CID86214047.
Singer O, Marr RA, Rockenstein E, Crews L, Coufal NG, Gage FH, et al. (October 2005). "Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model". Nature Neuroscience. 8 (10): 1343–9. doi:10.1038/nn1531. PMID16136043. S2CID6978101.
Niggeweg R, Michael AJ, Martin C (June 2004). "Engineering plants with increased levels of the antioxidant chlorogenic acid". Nature Biotechnology. 22 (6): 746–54. doi:10.1038/nbt966. PMID15107863. S2CID21588259.
Gilbert MK, Majumdar R, Rajasekaran K, Chen ZY, Wei Q, Sickler CM, et al. (June 2018). "RNA interference-based silencing of the alpha-amylase (amy1) gene in Aspergillus flavus decreases fungal growth and aflatoxin production in maize kernels". Planta. 247 (6): 1465–1473. Bibcode:2018Plant.247.1465G. doi:10.1007/s00425-018-2875-0. PMID29541880. S2CID3918937.
Katoch R, Thakur N (March 2013). "RNA interference: a promising technique for the improvement of traditional crops". International Journal of Food Sciences and Nutrition. 64 (2): 248–59. doi:10.3109/09637486.2012.713918. PMID22861122. S2CID45212581.
Katoch R, Thakur N (March 2013). "Advances in RNA interference technology and its impact on nutritional improvement, disease and insect control in plants". Applied Biochemistry and Biotechnology. 169 (5): 1579–605. doi:10.1007/s12010-012-0046-5. PMID23322250. S2CID23733295.
Huesken D, Lange J, Mickanin C, Weiler J, Asselbergs F, Warner J, et al. (August 2005). "Design of a genome-wide siRNA library using an artificial neural network". Nature Biotechnology. 23 (8): 995–1001. doi:10.1038/nbt1118. PMID16025102. S2CID11030533.
Romano N, Macino G (November 1992). "Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences". Molecular Microbiology. 6 (22): 3343–53. doi:10.1111/j.1365-2958.1992.tb02202.x. PMID1484489. S2CID31234985.
Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O'Riordan WD, Cochat P, et al. (1 April 2021). "Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1". The New England Journal of Medicine. 384 (13): 1216–1226. doi:10.1056/NEJMoa2021712. ISSN1533-4406. PMID33789010.
Adams D, Tournev IL, Taylor MS, Coelho T, Planté-Bordeneuve V, Berk JL, et al. (March 2023). "Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial". Amyloid. 30 (1): 18–26. doi:10.1080/13506129.2022.2091985. hdl:1959.4/unsworks_80922. ISSN1744-2818. PMID35875890.